EPS Revision Rally: ENHA Soars 38.5%, MRVL +30.2%, CMCT +34.5%
Today's top EPS revision plays delivered significant gains, led by ENHA (+38.5%) and CMCT (+34.5%). Marvell Technology (+30.2%) saw its upward revision amplified by S&P 500 inclusion news, while MAC (+9.3%) and HUM (+10.9%) posted steady gains on pure earnings estimate improvements.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| ENHA | Consumer Defensive | 2026-06-02 | N/A | +38.5% |
| CMCT | Real Estate | 2026-06-04 | N/A | +34.5% |
| MRVL | Technology | 2026-05-31 | N/A | +30.2% |
| HUM | Healthcare | 2026-06-03 | N/A | +10.9% |
| MAC | Real Estate | 2026-06-01 | +11.9pp | +9.3% |
Why did ENHA stock jump in June 2026?
ENHA jumped 38.5% (from $2.83 to $3.92) after analysts raised its forward EPS growth estimate to 140.4% on June 2.
As a Consumer Defensive stock, the revision signaled improving profitability in a sector benefiting from steady demand. With no company-specific news, the market's confidence in the revised EPS alone drove the rally.
ENHA EPS revision history → · Screener snapshot from 2026-06-02 →
FAQ: ENHA
Why did ENHA stock jump 38.5%?
ENHA surged after analysts raised its forward EPS growth estimate to 140.4% on June 2, driving investor confidence in the Consumer Defensive stock.
Is ENHA a buy after the rally?
While the revision signifies strong earnings momentum, the 38.5% gain suggests the market has priced in much of the improvement; investors should watch for any confirming news.
What is ENHA's EPS growth estimate?
ENHA's forward EPS growth estimate was raised to 140.4% as of the June 2 detection.
Why did CMCT stock jump in June 2026?
CMCT surged 34.5% (from $3.28 to $4.41) after analysts revised its forward EPS growth estimate up to 84.8% on June 4.
In the Real Estate sector, the upward revision came amid a broader recovery in REIT valuations. The lack of company-specific news suggests the market focused on the improved earnings outlook.
CMCT EPS revision history → · Screener snapshot from 2026-06-04 →
FAQ: CMCT
Why did CMCT stock surge 34.5%?
CMCT jumped after analysts raised its forward EPS growth estimate to 84.8% on June 4, signaling a turnaround in the Real Estate sector.
What caused CMCT's price increase?
The price increase was driven by the upward EPS revision, with no other news; the market responded to the improved earnings outlook.
What is CMCT's EPS growth estimate?
CMCT's current forward EPS growth estimate is 84.8%, revised upward on June 4.
Why did MRVL stock jump in June 2026?
MRVL jumped 30.2% (from $205.00 to $266.88) after analysts raised its forward EPS growth estimate to 50.7% on May 31.
The revision was reinforced by news of Marvell joining the S&P 500 on June 22 and CEO Jensen Huang calling it the 'next trillion dollar company,' which amplified buying momentum from passive index funds.
MRVL EPS revision history → · Screener snapshot from 2026-05-31 →
FAQ: MRVL
Why did MRVL stock jump 30.2%?
MRVL jumped after analysts raised its forward EPS growth estimate to 50.7% on May 31, with subsequent news of S&P 500 inclusion and strong AI chip demand amplifying the gain.
Is MRVL a buy after the rally?
MRVL's inclusion in the S&P 500 and booming custom AI chip business support the revised EPS, but the stock has more than tripled year-to-date; consider valuation risk.
What caused MRVL's surge?
The surge was triggered by an EPS revision and then reinforced by S&P 500 addition news and CEO Jensen Huang calling Marvell the 'next trillion dollar company.'
Why did HUM stock jump in June 2026?
HUM rose 10.9% (from $327.54 to $363.18) after analysts increased its forward EPS growth estimate to 74.9% on June 3.
As a healthcare insurer, the EPS revision reflected optimism in managed care margins. With no major news, the steady gain indicates investor confidence in the revised forecast.
HUM EPS revision history → · Screener snapshot from 2026-06-03 →
FAQ: HUM
Why did HUM stock rise 10.9%?
HUM rose after analysts increased its forward EPS growth estimate to 74.9% on June 3, reflecting improved managed care margins.
Is HUM a buy after the rally?
The EPS revision suggests strong future earnings, but the modest 10.9% gain may indicate room for further appreciation if targets are met.
What is HUM's EPS growth estimate?
HUM's forward EPS growth estimate is 74.9%, revised upward on June 3.
Why did MAC stock jump in June 2026?
MAC gained 9.3% (from $22.32 to $24.39) after analysts raised its forward EPS growth estimate from 129.7% to 141.6% on June 1.
The 11.9 percentage point revision signaled sharply improving earnings momentum in the Real Estate sector. The move was driven purely by the earnings revision as no news catalysts emerged.
MAC EPS revision history → · Screener snapshot from 2026-06-01 →
FAQ: MAC
Why did MAC stock gain 9.3%?
MAC gained after analysts raised its forward EPS growth estimate by 11.9 percentage points to 141.6% on June 1, signaling strong earnings recovery.
What caused MAC's surge?
The surge was caused by the sharp upward EPS revision in the Real Estate sector, with no other news catalysts.
What is MAC's EPS growth estimate?
MAC's forward EPS growth estimate was raised from 129.7% to 141.6% as of June 1.
The strong price reactions to EPS revisions across sectors suggest investors are closely monitoring earnings momentum and rewarding companies with improving forecasts, even in the absence of company-specific news.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →